Navigation Links
Perrigo Announces Approval for Rx Cetirizine Syrup
Date:6/19/2008

ALLEGAN, Mich., June 19 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Syrup (Rx only), 1mg/mL. The product is comparable to McNeil Consumer Healthcare's Zyrtec(R) Syrup, 1mg/mL, indicated for the relief of symptoms associated with seasonal allergic rhinitis.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This approval reflects both our strategy to be first to market with important products and the unique position of the Company both in front of and behind the pharmacy counter. This product will join our line of Cetirizine tablets, Cetirizine D and Cetirizine OTC syrup. Additionally, it contains active ingredient supplied by our own API business, a continuation of our vertical integration efforts. This is yet another example of how we are making quality healthcare more affordable for consumers."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to t
'/>"/>

SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Perrigo Confirms Filing for Generic Version of VANOS(R)
2. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
3. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
4. Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008
5. Perrigo Company Announces Quarterly Dividend
6. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
7. Perrigo Company Will Release Third Quarter Fiscal 2008 Results on May 6, 2008
8. Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack
9. Perrigo Company to Present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum
10. Perrigo Company Announces Launch of Clobetasol Propionate Foam
11. Perrigo Company Receives Final Approval on Clobetasol Propionate Foam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... University researchers have developed a way to detect and ... tiny gold particles with tails of synthetic DNA., A ... biological engineering, used gold nanoparticles to target and bind ... RNA splice variants, which can indicate the presence and ... splice variants in a cell can be determined by ...
(Date:4/23/2014)... A novel compound that targets an important brain receptor ... addiction behaviors, including relapse behavior, a University at Buffalo ... evidence that this may be a novel lead compound ... exist., The UB research was published as an online ... In the study, the compound, RO5263397, severely blunted a ...
(Date:4/23/2014)... 23, 2014Men whose testosterone falls below normal levels are ... overweight and have heart disease and type 2 diabetes. ... men for further testing and possible treatment is described ... , a peer-reviewed publication from Mary Ann Liebert, Inc., ... Journal of Men,s Health website at http://www.liebertpub.com/jmh ...
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... health benefits of probiotics, antioxidants and other nutritional compounds, ... chemical industry is getting in on the action. But ... so the industry is responding with clinical research to ... in Chemical & Engineering News (C&EN), the ... Melody M. Bomgardner, a senior editor at C&EN, writes ...
Breaking Medicine News(10 mins):Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2
... they travel, they pack a lunch. In results ... evolutionary biologists Joan Strassmann and David Queller of Rice ... known as slime molds) increase their odds of survival ... lead author Debra Brock, a graduate student at Rice, ...
... News) -- Many U.S. transplant surgeons unnecessarily shun organs ... safeguards that would protect and inform transplant recipients, a ... in the nation "overreacted" to a 2007 case in ... organs from a single donor unknowingly infected with HIV, ...
... HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay News) -- A ... II colon cancer face a higher risk of recurrence, German ... doctors in determining which patients need follow-up treatment after initial ... improvement on existing ways to predict recurrence, according to cancer ...
... who had not discussed life support measures with critically ... to forego further medical intervention than those who had ... the University of Pittsburgh School of Medicine and the ... in a poster presentation at the Society of Critical ...
... have been hot on the trail of a genetic mutation ... mutation,s discovery in 2008. The hunt is now yielding fruit. ... , researchers reveal how the mutation contributes to cancer development ... 75 percent of people with low-grade brain tumors and 20 ...
... January 18, 2011 HIV-positive head and neck cancer ... similar toxicity rates as non-HIV-positive patients, despite prior reports ... January issue of the International Journal of Radiation ... for Radiation Oncology (ASTRO). , Patients with HIV have ...
Cached Medicine News:Health News:Like humans, amoebae pack a lunch before they travel 2Health News:Gene Test Might Predict Colon Cancer's Return 2Health News:Gene Test Might Predict Colon Cancer's Return 3Health News:Pitt study: End-of-life decisions take longer if patient hasn't shared wishes with family 2Health News:Molecular battle in cancer cells offers clues for treatment 2Health News:HIV-positive head and neck cancer patients benefit from radiation therapy 2
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion Corporation (the ... it has received commitments from institutional investors to purchase ... common stock in an at-the-market registered direct offering, led ... Company entered into definitive purchase agreements with these investors ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... WALTHAM, Mass. , July 21 Alere Inc. ... ), a global leader in enabling individuals to take charge of ... health management, today announced that it will release its second quarter ... will also host a conference call beginning at 10:00 a.m. ...
... July 21 EndoChoice, Inc. today announced that it has moved ...  The new 30,000 square foot corporate headquarters is three times larger than ... , , ... a seamless move into our new corporate headquarters," stated EndoChoice CEO and ...
Cached Medicine Technology:Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results 2EndoChoice® Triples Facility Space to Address Growing Customer Base 2
... The ICD-9-CM contains the numerical list of ... for your Palm or Pocket PC PDA ... Ninth Revision, Clinical Modification (ICD-9-CM) is based ... International Classification of Diseases (ICD-9). ICD-9-CM is ...
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
Medicine Products: